Comparison between Prospect Commodities IPO and Sudarshan Pharma Industries IPO.
Prospect Commodities IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sudarshan Pharma Industries IPO is a SME Bookbuilding proposed to list at BSE SME.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Beeline Broking Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Prospect Commodities IPO is up to ₹7.10 Cr whereas the issue size of the Sudarshan Pharma Industries IPO is up to ₹47.58 Cr. The final issue price of Prospect Commodities IPO is ₹61.00 per share and of Sudarshan Pharma Industries IPO is ₹73.00 per share.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹71.00 per share | |
| Issue Price (Upper) | ₹73.00 per share | |
| Issue Price (Final) | ₹61.00 per share | ₹73.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 11,64,000 shares | 65,18,400 shares |
| Fresh Issue Size (Amount) | up to ₹7.10 Cr | up to ₹47.58 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 11,64,000 shares | 65,18,400 shares |
| Issue Size Total (Amount) | up to ₹7.10 Cr | up to ₹47.58 Cr |
Prospect Commodities IPO opens on Mar 08, 2023, while Sudarshan Pharma Industries IPO opens on Mar 09, 2023. The closing date of Prospect Commodities IPO and Sudarshan Pharma Industries IPO is Mar 13, 2023, and Mar 14, 2023, respectively.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Bid Date | Mar 08, 2023 | |
| Issue Open | Mar 08, 2023 | Mar 09, 2023 |
| Issue Close | Mar 13, 2023 | Mar 14, 2023 |
| Basis Of Allotment (Tentative) | Mar 16, 2023 | Mar 17, 2023 |
| Initiation of Refunds (Tentative) | Mar 17, 2023 | Mar 20, 2023 |
| Credit of Share (Tentative) | Mar 20, 2023 | Mar 21, 2023 |
| Listing date (Tentative) | Mar 20, 2023 | Mar 22, 2023 |
| Anchor Lockin End date 1 | Apr 16, 2023 | |
| Anchor Lockin End date 2 | Jun 15, 2023 |
Prospect Commodities IPO P/E ratio is 31.44, as compared to Sudarshan Pharma Industries IPO P/E ratio of 24.33.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.44 | 80.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 31.44 | 24.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24.95 Cr. | ₹175.68 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Prospect Commodities IPO Retail Individual Investors (RII) are offered 5,82,000 shares while in Sudarshan Pharma Industries IPO retail investors are offered 5,82,000 shares. Qualified Institutional Buyers (QIB) are offered in Prospect Commodities IPO and 5,21,600 shares in Sudarshan Pharma Industries IPO.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Investor Reserveration | 7,80,800 shares | |
| Market Maker Reserveration | 62,000 shares | 3,44,000 shares |
| QIB | 5,21,600 shares | |
| NII | 5,82,000 shares | 15,64,800 shares |
| RII | 5,82,000 shares | 36,51,200 shares |
| Employee | ||
| Others | ||
| Total | 11,64,000 shares | 65,18,400 shares |
Prospect Commodities IPO subscribed 5.31x in total, whereas Sudarshan Pharma Industries IPO subscribed 1.06x.
| Prospect Commodities IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| QIB (times) | 1.01x | |
| NII (times) | 6.85x | 0.81x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.76x | 1.20x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 5.31x | 1.06x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
